Design and experimental activities supporting commercial U.S. electron accelerator production of Mo-99
- Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545 (United States)
- Argonne National Laboratory, 9700 S. Cass Avenue, Argonne, IL 60439 (United States)
- NorthStar Medical Technologies, LLC, 5249 Femrite Drive, Madison, WI 53718 (United States)
{sup 99m}Tc, the daughter isotope of {sup 99}Mo, is the most commonly used radioisotope for nuclear medicine in the United States. Under the direction of the National Nuclear Security Administration (NNSA), Los Alamos National Laboratory (LANL) and Argonne National Laboratory (ANL) are partnering with North Star Medical Technologies to demonstrate the viability of large-scale {sup 99}Mo production using electron accelerators. In this process, {sup 99}Mo is produced in an enriched {sup 100}Mo target through the {sup 100}Mo({gamma},n){sup 99}Mo reaction. Five experiments have been performed to date at ANL to demonstrate this process. This paper reviews the current status of these activities, specifically the design and performance of the helium gas target cooling system.
- OSTI ID:
- 22116981
- Journal Information:
- AIP Conference Proceedings, Vol. 1525, Issue 1; Conference: 22. international conference on application of accelerators in research and industry, Ft. Worth, TX (United States), 5-10 Aug 2012; Other Information: (c) 2013 AIP Publishing LLC; Country of input: International Atomic Energy Agency (IAEA); ISSN 0094-243X
- Country of Publication:
- United States
- Language:
- English
Similar Records
ANSTO Synroc Wasteforms for the Immobilization of a Range of Mo-99 Production Wastes - 19326
A New Process for Small-Batch Purification of the Medical Isotope Molybdenum-99: Non-Technical Overview